ELLIPSOID ZONE RECOVERY IN MACULAR TELANGIECTASIA TYPE 2

被引:0
|
作者
Goerdt, Lukas [1 ]
Raming, Kristin [1 ]
Garcia, Jose Luis Rodriguez [1 ]
Pfau, Kristina [1 ,2 ]
Holz, Frank G. [1 ]
Herrmann, Philipp [1 ]
机构
[1] Univ Hosp Bonn, Dept Ophthalmol, Venusberg Campus 1, D-53315 Bonn, Germany
[2] Univ Hosp Basel, Dept Ophthalmol, Basel, Switzerland
关键词
dysflective cones; ellipsoid zone; macular telangiectasia type 2; neurodegeneration; recovery; OCT; END-STAGE; OCT; RESTORATION; VISION; REPAIR;
D O I
10.1097/IAE.0000000000004108
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To describe imaging features of macular telangiectasia type 2 eyes experiencing ellipsoid zone (EZ) recovery. Methods: Macular telangiectasia type 2 patients with EZ recovery were identified from the Natural History and Observational Registry study and underwent retinal imaging including optical coherence tomography and fundus photography. Eyes were graded according to the classification system by Gass and Blodi, the EZ-loss area was measured, and optical coherence tomography parameters were assessed by two independent readers. Parameters were analyzed for their presence before EZ recovery. Results: Twenty-four eyes of 21 patients (12 female, 57.12%; mean age 68 +/- 8.54 years) were included in this study and followed for 21.25 months +/- 12.79 months. At baseline, mean EZ-loss area was 0.036 mm(2) +/- 0.028 mm(2 )and 0.01 mm2 +/- 0.013 mm(2) at follow-up (P < 0.001). A persisting external limiting membrane overlaying the EZ-loss was detected in 16 cases (66%), and hyperreflective changes in the outer retina were present in 18 cases (75%). Best-corrected visual acuity was 0.23 (20/32) +/- 0.33 logMAR at baseline and 0.34 (20/40) +/- 0.34 logMAR at follow-up (P = 0.3). Conclusion: Distinct optical coherence tomography features precede ellipsoid zone recovery in macular telangiectasia type 2 and warrant further studies investigating implications for patient care and clinical trial interpretation.
引用
收藏
页码:1413 / 1421
页数:9
相关论文
共 50 条
  • [21] Macular Telangiectasia Type 2: A Comprehensive Review
    Kedarisetti, Kiran Chandra
    Narayanan, Raja
    Stewart, Michael W.
    Gurram, Nikitha Reddy
    Khanani, Arshad M.
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 3297 - 3309
  • [22] Metamorphopsia in patients with macular telangiectasia type 2
    Issa, Peter Charbel
    Holz, Frank G.
    Scholl, Hendrik P. N.
    DOCUMENTA OPHTHALMOLOGICA, 2009, 119 (02) : 133 - 140
  • [23] Genetic Background of Macular Telangiectasia Type 2
    Kuncic, Ajda
    Urbancic, Mojca
    Divjak, Darja Dobovsek
    Hudler, Petra
    Debeljak, Natasa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (02)
  • [24] Dark adaptation in macular telangiectasia type 2
    Tzaridis, Simone
    Hess, Kristina
    Heeren, Tjebo
    Mai, Clarissa
    Herrmann, Philipp
    Issa, Peter Charbel
    Holz, Frank G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [25] Management of Idiopathic Macular Telangiectasia Type 2
    Khodabande, Alireza
    Roohipoor, Ramak
    Zamani, Javad
    Mirghorbani, Masoud
    Zolfaghari, Hamidreza
    Karami, Shahab
    Modjtahedi, Bobeck S.
    OPHTHALMOLOGY AND THERAPY, 2019, 8 (02) : 155 - 175
  • [26] Sex steroids and macular telangiectasia type 2
    Mueller, Simone
    Allam, Jean-Pierre
    Bundzek, Chris
    Clemons, Traci E.
    Holz, Frank G.
    Issa, Peter Charbel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [27] Genetic Penetrance of Macular Telangiectasia Type 2
    Ronquillo, Cecinio C.
    Wegner, Kimberley
    Calvo, Charles M.
    Bernstein, Paul S.
    JAMA OPHTHALMOLOGY, 2018, 136 (10) : 1158 - 1163
  • [28] SEX STEROIDS AND MACULAR TELANGIECTASIA TYPE 2
    Mueller, Simone
    Allam, Jean-Pierre
    Bunzek, Christopher G.
    Clemons, Traci E.
    Holz, Frank G.
    Charbel, Peter
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 : S61 - S66
  • [29] Morphological characteristics in macular telangiectasia type 2
    Charbel, P.
    Heeren, T. F. C.
    Krueger, E.
    Zeimer, M.
    Pauleikhoff, D.
    Holz, F. G.
    OPHTHALMOLOGE, 2014, 111 (09): : 819 - 828
  • [30] Management of Idiopathic Macular Telangiectasia Type 2
    Alireza Khodabande
    Ramak Roohipoor
    Javad Zamani
    Masoud Mirghorbani
    Hamidreza Zolfaghari
    Shahab Karami
    Bobeck S. Modjtahedi
    Ophthalmology and Therapy, 2019, 8 : 155 - 175